6134-53-8

Basic information

• Product Name: 4-BroMo-2,3-dihydro-1H-indene
• Synonyms: 4-BroMo-2,3-dihydro-1H-indene;1H-Indene, 4-broMo-2,3-dihydro-;Indan, 4-bromo-
• CAS NO: 6134-53-8
• Molecular Formula: C₉H₉Br
• Molecular Weight: 197.07176
• EINECS: -0
• Mol File: 6134-53-8.mol

Chemical Properties

• Boiling Point: 118 °C(Press: 18 Torr)
• Appearance: /
• Density: 1.462±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-BroMo-2,3-dihydro-1H-indene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BroMo-2,3-dihydro-1H-indene(6134-53-8)
• EPA Substance Registry System: 4-BroMo-2,3-dihydro-1H-indene(6134-53-8)

Safety Data

• Hazardous Substances Data: 6134-53-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-Bromo-2,3-dihydro-1H-indene is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique chemical structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 4-Bromo-2,3-dihydro-1H-indene serves as a precursor for the production of various agrochemicals, including pesticides and herbicides. Its versatility in organic synthesis enables the creation of effective and targeted agrochemicals for agricultural use.
Used in Organic Synthesis:
4-Bromo-2,3-dihydro-1H-indene is utilized as a building block in organic synthesis for the development of a wide range of organic compounds. Its reactivity and structural properties make it a valuable component in the synthesis of complex organic molecules for various applications.
It is crucial to handle 4-Bromo-2,3-dihydro-1H-indene with caution, adhering to safety guidelines and consulting relevant safety data sheets and regulations to minimize potential health and environmental risks.

Upstream product

• 32202-61-2 4-aminoindan 
• 496-11-7 INDANE 
• 3433-80-5 1-Bromo-2-bromomethyl-benzene 
• 15115-58-9 3-(2-bromophenyl)propionic acid 
• 66192-11-8 diethyl 2-(2-bromobenzyl)propan-1,3-dioate 
• 95-46-5 2-methylphenyl bromide 
• 90725-40-9 3-(2-bromophenyl)propanoyl chloride 
• 166949-93-5 1-[3-(methylsulfonyloxy)propyl]-2-fluorobenzene 
• 446-52-6 2-Fluorobenzaldehyde 
• 76727-24-7 3-(2-fluorophenyl)propan-1-ol 
• 18944-77-9 2-fluorocinnamic acid 
• 1643-26-1 3-(2-fluorophenyl)propionic acid 
• 7726-95-6 bromine 
• 64-19-7 acetic acid 

Downstream Products

• 116-69-8 3-bromophthalic acid 
• 1252793-57-9 2-(2,3-dihydro-1H-inden-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 93319-37-0 2--benzoesaeure 
• 641-48-5 aceanthrene 
• 824-22-6 2,3-dihydro-4-methyl-1H-indene 
• 5385-32-0 4-Indanyl-<4-methoxy-phenyl>-keton 
• 5385-30-8 <4>Indanyl-p-tolyl-keton 
• 5385-28-4 indan-4-yl-phenyl ketone 
• 5385-31-9 4-Indanyl-<2-methoxy-phenyl>-keton 
• 5385-33-1 4-Indanyl-<4-methylmercapto-phenyl>-keton 
• 5385-29-5 <4>Indanyl-o-tolyl-keton 
• 93321-55-2 2-(Indanyl-⁽⁴⁾-formyl)-benzoesaeure 

Relevant articles and documents

Aromatic amine derivative organic electroluminescent material and device thereof

The invention discloses an aromatic amine derivative organic electroluminescent material and a device thereof. The compound is a pyrene compound substituted with an aromatic amine, wherein the compound has a substituted or unsubstituted (hetero) aryl group and a pyrene compound substituted or unsubstituted aromatic amine structure of a (hetero) aryl group, which may be used as a light emitting material in an organic electroluminescent device. These novel compounds can provide better device performance, such as higher external quantum efficiency and narrower half-peak widths, and the like.

INFLUENZA VIRUS REPLICATION INHIBITOR AND USES THEREOF

The invention belongs to the field of medicine, and particularly relates to a novel compound as a replication inhibitor of influenza virus and a preparation method thereof, a pharmaceutical composition comprising the compound and use of the compound and pharmaceutical composition thereof in treating influenza. The present invention provides a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, The compound of the present invention can inhibit influenza virus well, and/or has lower cytotoxicity, better in vivo pharmacokinetic properties and in vivo pharmacodynamic properties.

SHMT INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

NOVEL NEUROKININ 1 RECEPTOR ANTAGONIST COMPOUNDS II

The invention relates novel NK1 receptor antagonists represented in formula A, wherein R1 and R2 independently are selected from the group consisting of (C1-4)alkyl, (C1-4)haloalkyl, (C1-4)alkoxy, CD

FUSED HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS

Fused heterocyclic compounds useful for prevention, treatment or improvement of diseases against which activation of the thrombopoietin receptor is effective are provided. A compound represented by the formula (I) (wherein R1 is an aryl group fused to a saturated ring or the like, A, B, L1, R2, L2, L3, Y, L4, R3 and X are defined in the description), a tautomer, prodrug or a pharmaceutically acceptable salt of the compound or a solvate thereof.

SUBSTITUTED PARA-BIPHENYLOXYMETHYL DIHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF

The present invention relates to a series of substituted para-biphenyloxymethyl dihydro oxazolopyrimidinones of formula (I) as defined herein. This invention also relates to methods of making these compounds including novel intermediates. The compounds of

Anti-cancer agents and uses thereof

The present invention is in the area of novel compounds and salts thereof, their syntheses, and their use as anti-cancer agents. The compounds include compounds of Formula I: and solvates, hydrates and pharmaceutically-acceptable salts thereof, wherein A1 is N or CR1; A3 is N or CR3; A5 is N or CR5; R1, R3-R6 and L are defined in the specification; n is 0 or 1; and X is an optionally-substituted aryl group having 6-10 carbons in the ring portion, an optionally-substituted 6-membered heteroaryl group having 1-3 nitrogen atoms in the ring portion, an optionally-substituted 5-membered heteroaryl group having 0-4 nitrogen atoms in the ring portion and optionally having 1 sulfur atom or 1 oxygen atom in the ring portion, or an optionally-substituted heteroaryl group in which a 6-membered ring is fused either to a 5-membered ring or to a 6-membered ring, wherein in each case 1, 2, 3 or 4 ring atoms are heteroatoms independently selected from nitrogen, oxygen and sulfur. They are effective against a broad range of cancers, especially leukemia, prostate, non-small cell lung and colon. They are additionally useful in the treatment of proliferative retinopathies such as diabetic neuropathy and macular degeneration.

Anti-cancer agents and uses thereof

The present invention is in the area of novel compounds and salts thereof, their syntheses, and their use as anti-cancer agents. The compounds include compounds of Formula I: and solvates, hydrates and pharmaceutically-acceptable salts thereof, wherein A1 is N or CR1; A3 is N or CR3; A5 is N or CR5; R1, R3—R6 and L are defined in the specification; n is 0 or 1; and X is an optionally-substituted aryl group having 6-10 carbons in the ring portion, an optionally-substituted 6-membered heteroaryl group having 1-3 nitrogen atoms in the ring portion, an optionally-substituted 5-membered heteroaryl group having 0-4 nitrogen atoms in the ring portion and optionally having 1 sulfur atom or 1 oxygen atom in the ring portion, or an optionally-substituted heteroaryl group in which a 6-membered ring is fused either to a 5-membered ring or to a 6-membered ring, wherein in each case 1, 2, 3 or 4 ring atoms are heteroatoms independently selected from nitrogen, oxygen and sulfur. They are effective against a broad range of cancers, especially leukemia, non-small cell lung and colon.

A simple and improved procedure for selective ring bromination of alkyl-substituted aromatic hydrocarbons on the surface of alumina

Highly selective ring bromination of alkyl-substituted aromatic hydrocarbons has been achieved using molecular bromine adsorbed on the surface of alumina without any solvent.